Price$295.17-2.12 (-0.71%)
01:30 PM07:45 PM
News · 26 weeks94-52%
2025-12-072026-05-31
Mix5890d
- Insider30(52%)
- Other15(26%)
- SEC Filings10(17%)
- Leadership1(2%)
- Analyst1(2%)
- Earnings1(2%)
Latest news
25 items- INSIDERPresident and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker launches TPX HD® power tool, supporting demanding orthopaedic proceduresPORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures. "Revision procedures are some of the most demanding cases surgeons face, especially when metal cutting is involved," said Mike Carlin, president of Stryker's Ortho Tech division. "TPX HD was designed with tho
- INSIDERVP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker Launches Pangea Plating System and Completes First Case in EuropeStryker (NYSE:SYK), a global leader in medical technologies, announced today the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns. Prof. Alex Trompeter, design surgeon and orthopaedic trauma surgeon, along with his team at St. George's University Hospital in London, completed the first clinical case in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525326817/en/Stryker's Pangea Plating System brings together thoughtfully designed plates and a streamlined instrumentation set, giving surgeons practical options when treating a range of fractures. "Pan
- SECSEC Form SD filed by Stryker CorporationSD - STRYKER CORP (0000310764) (Filer)
- SECSEC Form 8-K filed by Stryker Corporation8-K - STRYKER CORP (0000310764) (Filer)
- PRBioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech EcosystemThree companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in the expansion of its peripheral vascular portfolio. All three companies have close t
- INSIDERVP, Chief HR Officer Fink M Kathryn exercised 21,582 shares at a strike of $167.98, covered exercise/tax liability with 16,362 shares and sold $2,473,756 worth of shares (8,720 units at $283.69) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- SECSEC Form 10-Q filed by Stryker Corporation10-Q - STRYKER CORP (0000310764) (Filer)
- INSIDERDirector Suri Rajeev was granted 762 shares, increasing direct ownership by 12% to 7,190 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Stryker Ronda E was granted 762 shares, increasing direct ownership by 136% to 1,322 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Skeete Tatum Lisa M was granted 762 shares, increasing direct ownership by 17% to 5,205 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Silvernail Andrew K was granted 762 shares, increasing direct ownership by 4% to 18,465 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Ruggeri Rachel was granted 762 shares, increasing direct ownership by 62% to 2,001 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Mccoy Sherilyn S was granted 762 shares, increasing direct ownership by 12% to 7,190 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Maceda Emmanuel Perez was granted 762 shares, increasing direct ownership by 136% to 1,322 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Caforio Giovanni was granted 762 shares, increasing direct ownership by 20% to 4,530 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Brainerd Mary K was granted 762 shares, increasing direct ownership by 11% to 7,790 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERVP, Chief Comm. Officer Montagnino Kimberly Ann was granted 677 shares, increasing direct ownership by 57% to 1,872 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDEROfficer King Debra was granted 1,016 shares, increasing direct ownership by 16% to 7,569 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- SECStryker Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - STRYKER CORP (0000310764) (Filer)
- PRStryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolioPortage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. "This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease," said Kevin Lobo, Chair and CEO, Stryker. "By integrating AVS's innovative CO₂-generated pressure wave technology with Stryker's scale and resources, we are well-positioned to deliver solutions that support p
- PRStryker declares an $0.88 per share quarterly dividendPortage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 m
- PRStryker to participate in the Bank of America Securities 2026 Global Healthcare ConferencePortage, Michigan, May 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Spencer Stiles, President and Chief Operating Officer, Jason Beach, Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology and Nick Mead, Vice President, Investor Relations. Their presentation is scheduled for 1:40 p.m. Pacific Time. A live webcast and replay of the presentation will be accessible on Stryker's website at www.stryker.com, and it will be archived on the Investor Relations page. About Stryke
SYK FAQ
7 questionsWhat does Stryker Corporation do?
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various...Where does SYK stock trade?
Stryker Corporation (SYK) is listed on NYSE.What sector and industry is SYK in?
Stryker Corporation operates in the Health Care sector, Medical/Dental Instruments industry.Does SYK pay a dividend?
Yes. SYK's next ex-dividend date is 2026-06-30 with a declared cash dividend of $0.88 per share, payable 2026-07-31.What are analysts saying about SYK?
Stryker Corporation has had 8 recent analyst actions on file. The most recent action was from Leerink Partners: Outperform on 2026-04-13.What companies are similar to SYK?
Notable peers in the same industry include JNJ (Johnson & Johnson), MDT (Medtronic plc.), BDX (Becton Dickinson and Company), ZBH (Zimmer Biomet Holdings Inc.), BAX (Baxter International Inc.). Compare SYK side-by-side with any of them on Quantisnow.How can I track SYK on Quantisnow?
Quantisnow aggregates Stryker Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SYK to receive live email and push alerts on every new disclosure.